sexta-feira, 13 de novembro de 2026
PesquisarExplore
Via News Knowledge File

Apple Podcasts

organization80% conf.·synced Aug 13, 2026

Major podcast platform at forefront of personalized recommendation algorithms and content distribution

27
sourced metrics
435
relationships
10
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
252.89USD
Buyback Spending
816billion_USD
Shares Retired
44percent
Etf Weight
14.33percent
Forward Pe Ratio
33ratio
Portfolio Weight Vgt
15.8percent
Portfolio Weight
15.8percent
Unit Shipments
220000000iPhones
Market Share
90percent
Portfolio Weight In Qqq
7.33percent
Jul 2, 2026source
Investment Return On Double Down
51615USD
Apr 27, 2026source
Market Cap
4000USD
Apr 20, 2026source
Ownership Stake
20percent
Apr 2, 2026source
Index Weight
6.6percent
Mar 27, 2026source
Price To Earnings Ratio
32ratio
Mar 25, 2026source
Portfolio Percentage
20.1percent
Jan 1, 2026source
Share Buyback Total
816billion_USD
Dec 1, 2025source
Shares Repurchased
44percent
Dec 1, 2025source

Stated objectives

Ramp up development and release of three new AI wearable devices: glasses, pendant, and AirPods built around Siri

source
stated

Extend integrated hardware strategy into cloud by combining performance with sovereignty through proprietary AI infrastructure

source
by 2026-01-01 00:00:00stated

Become net zero carbon emissions

source
target: net zero by 2030-01-01 00:00:00stated

Sprint to build in-house chips and accelerate Apple silicon development

source
stated

Launch first foldable iPhone to build brand buzz around incoming CEO John Ternus and capture premium device segment

source
target: 2000 USD per unit stated

Launch revamped Siri powered by Gemini as its foundation model

source
by 2026-01-01 00:00:00stated

Obtain White House approval to purchase semiconductor chips from Chang Xin Memory Technologies despite its Pentagon blacklist status

source
stated

Favor better on-device processing of third-party AI software over building competing generative AI, lowering overspending risk

source
stated

Give customers a more flexible way to pay for Apple products through a leasing program available both online and in-store.

source
stated

Make a big smart home push with Siri AI at the center

source
stated

Relationship graph · 435 connections

Developed by
90
Competes with
64
Invested in
60
Supplies to
41
Employs
27
Owns
26
Customer of
23
Covered by
22
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com